Delivery Order SPE2DB22D2009-SPE2DB25FM0SG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,346.88 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive award under the company's broader indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,262.40 to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (180-count), with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $13,992.61 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $23,316.22 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) under a firm fixed price contract. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count) valued at $3,510.76. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this pharmaceutical supply transaction, which will be fulfilled from...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,718.16 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count units). This firm fixed-price delivery order, awarded on July 31, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of August 1, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $14,010.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units). The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,962.22 on August 4, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,013.67 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $22,834.45 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Entresto 49 mg-51 mg tablets (180 count). This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award utilizing the company's existing indefinite delivery contract vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0SGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,281.85 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180 count) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million and extends through December 2026. This prime IDV functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The award reflects AmerisourceBergen Drug Corp's demonstrated capability to meet federal procurement requirements for specialized pharmaceutical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 8/5/25 |